false
Teresa Pokladowski
Teresa is a respected business development strategist, building successful clinical programs for clients in Massachusetts. She is an innovator of fresh approaches to biomarker planning, translational solutions, and clinical study design. Her experience spans the execution of Phase 1-4 clinical trials, specialty lab services, companion and in vitro diagnostic strategies, and biomarker data management.
-
Read: Challenges & Opportunities in Cell and Gene Therapy Challenges & Opportunities in Cell and Gene Therapy
-
Read: How European Oncology Site Networks Streamline Clinical Trial Site Selection How European Oncology Site Networks Streamline Clinical Trial Site Selection
| -
Read: Clinical Trial Trends: Early Phase Oncology Discover -
Read: The Dose Dilemma: Lessons from Sotorasib and the Future of Oncology Drug Optimization The Dose Dilemma: Lessons from Sotorasib and the Future of Oncology Drug Optimization
| -
Read: Why Antibody-Drug Conjugates Are Revolutionizing Precision Oncology Discover -
Read: Therapeutic Genome Editing – Reshaping the Landscape of Advanced Therapies Therapeutic Genome Editing – Reshaping the Landscape of Advanced Therapies
| -
Read: Clinical Trial Trends: Non-Hodgkin’s Lymphoma Discover -
Read: US Crackdown on Chinese Clinical Trials: What’s at Stake for Biopharma? Discover -
Read: Safety isn’t a Milestone but a Mindset in Clinical Research Discover
Loading...
You've reach the end